# A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participant

Source: https://onco.cc/trials/nct06149286/  
OnCo record `nct06149286` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Odronextamab, Lenalidomide, Rituximab in follicular lymphoma, run by Regeneron Pharmaceuticals, now recruiting.

## Summary

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma is a phase 3 interventional study registered as NCT06149286 by Regeneron Pharmaceuticals, with 580 participants planned, started 2023-12-28 and due to reach its primary completion in 2031-04-30. Interventions recorded: Odronextamab, Lenalidomide, Rituximab. Conditions listed: Relapsed/Refractory Follicular Lymphoma, Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL). No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: ctgov-ingest
- Registry id: NCT06149286
- Phase: 3
- Setting: A Phase 3, Open Label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Combination With Lenalidomide Versus Rituximab in Combination With Lenalidomide in Relapsed/Refractory Participants With Follicular Lymphoma and Marginal Zone Lymphoma (OLYMPIA-5)
- Sponsor: Regeneron Pharmaceuticals
- Enrolled: 580

## Sources

- ClinicalTrials.gov NCT06149286: https://clinicaltrials.gov/study/NCT06149286

## Connected records

- cancers: [Follicular lymphoma](https://onco.cc/cancers/follicular-lymphoma/)
- drugs: [Lenalidomide](https://onco.cc/drugs/lenalidomide/), [Odronextamab](https://onco.cc/drugs/odronextamab/), [Rituximab](https://onco.cc/drugs/rituximab/)
- companies: [Regeneron](https://onco.cc/companies/regeneron/)

---
JSON: https://onco.cc/api/v1/entities/nct06149286.json